K. Koelsch

发表

CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals

D. Cooper, A. Kelleher, J. Zaunders, 2016, Front. Immunol..

The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: design and methods

D. Cooper, A. Kelleher, B. Grinsztejn, 2014, BMC Public Health.

Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity

N. Sarvetnick, C. King, A. Ilic, 2004, Cell.

Progressive Activation of CD127+132− Recent Thymic Emigrants into Terminally Differentiated CD127−132+ T-Cells in HIV-1 Infection

D. Cooper, A. Kelleher, J. Zaunders, 2012, PloS one.

Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting.

V. Natarajan, D. Cooper, A. Kelleher, 2013, AIDS research and human retroviruses.

HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells

B. Autran, D. Cooper, S. Alcântara, 2017, Front. Immunol..

CD73+ CD127high Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 Infection

S. Kent, A. Kelleher, J. Zaunders, 2021, International journal of molecular sciences.

Primary HIV infection alters brain neurochemistry, but does antiretroviral treatment help?

L. Cysique, K. Koelsch, 2014, Neurology.

Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.

S. Lewin, D. Cooper, D. Smit, 2013, The Journal of infectious diseases.

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

R. Haubrich, R. Shafer, D. Richman, 2008, The Journal of infectious diseases.

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

T. Phan, A. Kelleher, J. Zaunders, 2021, Frontiers in Immunology.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

M. Churchill, D. Cooper, A. Kelleher, 2019, Journal of virus eradication.

The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells.

D. Cooper, A. Kelleher, J. Zaunders, 2013, AIDS research and human retroviruses.

Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 Infection

E. Rosenberg, B. Walker, J. Kaldor, 2006, Journal of Virology.

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

G. Pantaleo, M. Tolstrup, R. Fromentin, 2015, PLoS pathogens.

Peripheral Blood Mononuclear Cells HIV DNA Levels Impact Intermittently on Neurocognition

B. Brew, L. Cysique, Nadene Dermody, 2015, PloS one.

HIV-1 DNA predicts disease progression and post-treatment virological control

M. Carrington, R. Phillips, D. Cooper, 2014, eLife.

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

D. Cooper, A. Kelleher, M. Munier, 2010, Cytokine.

Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus

D. Richman, S. Little, C. Petropoulos, 2003, AIDS.

Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection

S. Kent, A. Kelleher, J. Zaunders, 2017, Front. Immunol..

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

R. Phillips, D. Cooper, C. Willberg, 2015, Nature Communications.

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels

V. Natarajan, D. Cooper, A. Kelleher, 2015, AIDS.

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.

D. Havlir, J. Wong, M. Strain, 2005, The Journal of infectious diseases.

Incidence of HIV superinfection following primary infection.

D. Richman, S. Little, E. Daar, 2004, JAMA.

Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.

A. Phillips, J. Lundgren, J. Neaton, 2016, The Journal of infectious diseases.

O20.3 Hiv transmission in male serodiscordant couples in australia, thailand and brazil

B. Grinsztejn, G. Prestage, A. Grulich, 2015 .

HIV drug resistance acquired through superinfection

D. Richman, S. Little, C. Petropoulos, 2005, AIDS.

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals

S. Lewin, D. Cooper, A. Kelleher, 2017, Journal of acquired immune deficiency syndromes.

HIV dynamics linked to memory CD4+ T cell homeostasis

D. Cooper, A. Kelleher, J. Zaunders, 2017, PloS one.

Integrase inhibitors in salvage therapy regimens for HIV-1 infection

D. Cooper, David A Cooper, Kersten K Koelsch, 2009, Current opinion in HIV and AIDS.

Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)

S. Lewin, A. Kelleher, J. Zaunders, 2020, Clinical Infectious Diseases.

Altered immune reconstitution in HIV positive allogeneic stem cell transplant recipients.

S. Lewin, A. Kelleher, J. Zaunders, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir

V. Natarajan, D. Cooper, A. Kelleher, 2011, AIDS.

Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards

D. Cooper, A. Kelleher, J. Zaunders, 2012, AIDS.

HIV DNA Subspecies Persist in both Activated and Resting Memory CD4+ T Cells during Antiretroviral Therapy

D. Cooper, A. Kelleher, J. Zaunders, 2014, Journal of Virology.

Switching Virally Suppressed, Treatment-Experienced Patients to a Raltegravir-Containing Regimen Does Not Alter Levels of HIV-1 DNA

D. Cooper, A. Kelleher, J. Amin, 2012, PloS one.

HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure.

D. Cooper, A. Leigh Brown, A. Kelleher, 2019, AIDS research and human retroviruses.

Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy.

D. Cooper, A. Kelleher, J. Zaunders, 2017, AIDS research and human retroviruses.

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

M. Tolstrup, R. Fromentin, N. Chomont, 2015, PLoS Pathogens.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

M. Churchill, D. Cooper, A. Kelleher, 2019, Journal of virus eradication.

Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.

S. Lewin, D. Cooper, D. Smit, 2013, The Journal of infectious diseases.

Biomarker reveals HIV's hidden reservoir Determining the total amount of HIV DNA in people undergoing antiretroviral therapy could accelerate the development of novel therapies and potential cures for HIV infection.

N. Robinson, G. Tambussi, K. Koelsch, 2014 .